E.g., 11/24/2024
E.g., 11/24/2024

bioMérieux Receives AOAC Official Methods Approval for VIDAS® UP LPT and VIDAS® LMX, Delivering Fast, Sensitive Total Listeria Detection

28 June, 2013

Fast-tracked, simultaneous AOAC OMA approval of two assays marks the significance of this complete Listeria package.

bioMérieux Receives FDA Approval for THxID®-BRAF Companion Diagnostic Test

30 May, 2013

The only CE-marked and FDA-approved BRAF test able to simultaneously detect 2 BRAF mutations, V600E and V600K providing high medical value information to select treatment for metastatic melanoma patients.

Important Announcement Regarding Our Logistics and Warehouse Management Systems

27 May, 2013

As part of our ongoing commitment to process improvement, bioMérieux will be upgrading its logistics and warehouse management systems in the coming months.

bioMérieux Presents 2013 Sonnenwirth Award for Leadership in Clinical Microbiology to Roberta B. Carey, Ph.D. of the Centers for Disease Control and Prevention (CDC)

20 May, 2013

bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce Roberta B. Carey, Ph.D as the 2013 recipient of the bioMérieux Sonnenwirth Award for Leadership in Clinical Microbiology. The award will be given during the 2013 General Meeting of the American Society for Microbiology (ASM) awards dinner in Denver on Sunday, May 19. Given in memory of Alexander Sonnenwirth, Ph.D., the award honors a top microbiologist for her or his innovation in clinical laboratory science, dedication to ASM and leadership in the microbiology field.

bioMérieux Offers LabScore Grading for Microbiology Laboratory Professionals at the 2013 General Meeting of the American Society for Microbiology

20 May, 2013

bioMérieux Will Feature Presentations Detailing the Revolutionary Potential of MALDI-TOF Mass Spectrometry Technology for Microbial Identification.

bioMérieux to Feature Sepsis Solutions at New York Meeting of the American Society for Microbiology

05 April, 2013

Sepsis is Top of Mind for New York Healthcare Providers as Rory’s Regulation, a Law Before New York Legislators Now, Proposes to Mandate All Hospitals Adopt New Protocols for Sepsis Identification and Treatment.

bioMérieux Teams Up with Clot Connect to Promote Early Diagnosis of Potentially Fatal Blood Clots

19 March, 2013

Deep-vein thrombosis (DVT) awareness is key to saving lives from this condition which kills as many as 300,000 people each year in the U.S.

bioMérieux - 2012 Financial Results

13 March, 2013

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review the full-year of 2012.

bioMérieux Opens a Subsidiary in Vietnam

04 December, 2012

bioMérieux Opens a Subsidiary in Vietnam, Strengthening its Footprint in High-growth Southeast Asia

bioMérieux Launches VIDAS® LPT, a Fast, Ground-Breaking Listeria Detection Method

14 November, 2012

VIDAS® UP Recombinant Phage Technology Delivers Unprecedented Specificity and Sensitivity for Rapid and Reliable Testing of Listeria spp

Pioneering Diagnostics